SECreport

Form 4 Cue Biopharma, Inc. For: Mar 24 Filed by: Pienta Kenneth

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases